Atlas Trials

Aerie Pharmaceuticals

36 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Aerie Pharmaceuticals

RecordFirmDate
A Long-Term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512 (NCT05493111)Aerie Pharmaceuticals2022-11-01
Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3) (NCT05360966)Aerie Pharmaceuticals2022-07-18
Study Evaluating the Safety and Efficacy of AR-15512 (NCT05285644)Aerie Pharmaceuticals2022-05-09
Rocklatan® Evaluation (NCT05283395)Aerie Pharmaceuticals2022-03-28
Study Evaluating Techniques for Measuring Tear Production (NCT05497479)Aerie Pharmaceuticals2021-12-09
Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT04620135)Aerie Pharmaceuticals2020-11-30
A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease (NCT04498182)Aerie Pharmaceuticals2020-10-26
A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy (NCT04498169)Aerie Pharmaceuticals2020-09-17
A Study Assessing AR-13503 Implant in Subjects With nAMD or DME (NCT03835884)Aerie Pharmaceuticals2019-06-24
Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan (NCT03844945)Aerie Pharmaceuticals2019-03-19
Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting (NCT03808688)Aerie Pharmaceuticals2018-12-27
Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension (NCT03310580)Aerie Pharmaceuticals2017-11-15
Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (NCT03233308)Aerie Pharmaceuticals2017-10-20
Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension (NCT03284853)Aerie Pharmaceuticals2017-09-05

Track Aerie Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.